Find similar content

Source channel @githubtrending · Post #15261 · Nov 2

#javascript#123pan#139_cloud#189_cloud#ali_netdisk#aliyun_drive#aria2#baidu#baidu_netdisk#baidunetdisk#baiduyun#motrix#quark_netdisk#tampermonkey#tampermonkey_script#tampermonkey_userscript#tianyi_netdisk#uc_netdisk#userscript#xunlei_netdisk#yidong_netdisk LinkSwift is a browser script that helps you quickly get direct download links for files stored on popular Chinese cloud services like Baidu, Alibaba, 123, and others—saving you time and making downloads easier without needing to visit each service’s website separately. It also improves the look of these cloud storage pages and adds extra features, such as support for different download tools and customizable themes. The main benefit is convenience: you can manage and download your cloud files faster, with a nicer interface, all from your browser. Just install the script using a tool like Tampermonkey, and it works on Chrome, Edge, and other major browsers. https://github.com/hmjz100/LinkSwift

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment